Stabilized gp120-specific CD4 for next-generation HIV-1 inhibitors
Adrian J. Bahn-Suh, Luis F. Caldera, Priyanthi N.P. Gnanapragasam…·Stephen L. Mayo
This paper develops a gp120-specific CD4 variant (gCD4) that improves thermostability, reduces off-target class II MHC binding, and enhances HIV-1 neutralization compared to existing CD4-Ig biologics.